Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

Abstract Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than th...

Full description

Saved in:
Bibliographic Details
Main Authors: Rena Eudy‐Byrne, Nicole Zane, Susan C. Adeniyi‐Jones, Marc R. Gastonguay, Ana Ruiz‐Garcia, Gagan Kushal, Walter K. Kraft
Format: article
Language:EN
Published: Wiley 2021
Subjects:
Therapeutics. Pharmacology
RM1-950
Public aspects of medicine
RA1-1270
Online Access:https://doaj.org/article/36acd5d7a6f74a369d135df943dae29b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/36acd5d7a6f74a369d135df943dae29b

Similar Items